TEDMED | What if a pinch of Baker’s yeast could be the recipe to solve complex neurological diseases? @TEDMED | Uploaded March 2018 | Updated October 2024, 18 hours ago.
Chee Yeun Chung is Scientific Co-founder and Associate Director of Assay Development at Yumanity Therapeutics, a company working to develop new treatments for neurodegenerative diseases that are caused from protein misfolding. Currently, there are over 55 million people affected by these diseases, with no effective cures or treatment options to improve their conditions. Watch Chee's 2017 TEDMED Hive Talk to learn more about Yumanity's goal to develop novel therapies aimed at improving the prognosis for the millions of patients affected by neurodegenerative diseases worldwide.
Chee Yeun Chung is Scientific Co-founder and Associate Director of Assay Development at Yumanity Therapeutics, a company working to develop new treatments for neurodegenerative diseases that are caused from protein misfolding. Currently, there are over 55 million people affected by these diseases, with no effective cures or treatment options to improve their conditions. Watch Chee's 2017 TEDMED Hive Talk to learn more about Yumanity's goal to develop novel therapies aimed at improving the prognosis for the millions of patients affected by neurodegenerative diseases worldwide.
